Company Overview

Update
Headquarters:
Liverpool
Funding:
$880.90k
Categories:
Biotechnology

TTS Pharma is a UK-based biotechnology company developing technologies to support the pharmacogenetic stratification of patients.

Description

Update

TTS Pharma was formed in late 2012 to acquire Transdermal Technology & Systems (TTS) Limited as part of a strategic investment and corporate restructuring to prepare it for growth and to enable the group to undertake activities in both Europe and Asia. TTS Limited is a wholly owned subsidiary of TTS Pharma and undertakes its operating activities primarily in UK.

Funding Rounds (1) - $880.90k

Update

Investors (1)

Update
  • 2437abc9b8d370018069779b39b92eba

    The North West Fund

    The North West Fund is an evergreen investment fund established to provide debt and equity funding..

Offices/Locations (1)

Update
  • Office

    Liverpool Science Park

    131 Mount Pleasant

    Liverpool, L3 5TF

    GBR

Images (1)

Update
  • 44e3d98619e070e685ba6c8b0e697079